Publication:
Comparative Effectiveness and Persistence of Cladribine Tablets From Glimpse: Results From the Msbase Registry

dc.authorwosidOzakbas, Serkan/V-6427-2019
dc.contributor.authorButzkueven, H.
dc.contributor.authorSpelman, T.
dc.contributor.authorOzakbas, S.
dc.contributor.authorAlroughani, R.
dc.contributor.authorTerzi, M.
dc.contributor.authorHodgkinson, S.
dc.contributor.authorWong, S.
dc.date.accessioned2025-12-11T00:40:08Z
dc.date.issued2022
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Butzkueven, H.; Van der Walt, A.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic, Australia; [Spelman, T.] MSBase Fdn, Alfred Ctr, Melbourne, Vic, Australia; [Ozakbas, S.] Dokuz Eylul Univ, Izmir, Turkey; [Alroughani, R.] Amiri Hosp, Sharq, Kuwait, Kuwait; [Terzi, M.] Mayis Univ, Samsun, Turkey; [Hodgkinson, S.] Liverpool Hosp, Sydney, NSW, Australia; [Laureys, G.] Univ Hosp Ghent, Ghent, Belgium; [Kalincik, T.] Royal Melbourne Hosp, Dept Neurol, MS Ctr, Melbourne, Vic, Australia; [Tundia, N.; Wong, S.] EMD Serono Res Dev Inst Inc, Billerica, MA USAen_US
dc.description.sponsorshipMercken_US
dc.description.sponsorshipThis study was sponsored by Merck (CrossRef Funder ID: 10.13039/100009945).en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.endpage290en_US
dc.identifier.issn1351-5101
dc.identifier.issn1468-1331
dc.identifier.scopusqualityQ1
dc.identifier.startpage289en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/38294
dc.identifier.volume29en_US
dc.identifier.wosWOS:000815254001155
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofEuropean Journal of Neurologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleComparative Effectiveness and Persistence of Cladribine Tablets From Glimpse: Results From the Msbase Registryen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files